NCT06147492Completed
Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer
Urinary Retention Following Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
Yanhong DengClinicalTrials.govprocedure
Study focus
- Disease/Condition
- Rectal Cancer
- Drug/Device/Intervention
- transanal total mesorectal excision
- Study type
- Interventional
- Intervention type
- procedure
Sponsor & location
- Primary sponsor
- Yanhong Deng
- Funder
- Sun Yat-sen University
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 30, 2016
- End date
- Oct 30, 2023
- Enrollment
- 526 participants
Primary outcome
urinary retention
Summary
A comprehensive study with prospectively collected data. These patients were assigned to
 either the taTME group or the laTME group according to the surgery procedure received
ICD-10 classifications
Malignant neoplasm of rectumCarcinoma in situ: RectumBenign neoplasm: RectumSecondary malignant neoplasm of large intestine and rectumCarcinoma in situ: Rectosigmoid junction
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06147492
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06147492 through Pure Global AI's free database. This phase not specified trial is sponsored by Yanhong Deng and is currently Completed. The study focuses on Rectal Cancer. Target enrollment is 526 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.